IDEXX Laboratories, Inc.
IDXX · Healthcare · · USDFahodi Score HOLD Short-term (Swing)
63
/ 100
Technical
60
Trend & RS
75
Momentum
88
Fundamental (0%)
67
Macro
24
Liquidity
65
| Component | Score | Weight |
|---|---|---|
| Technical | 60.0 | 40% |
| Trend & RS | 75.1 | 20% |
| Momentum | 88.2 | 20% |
| Fundamental | 66.7 | 0% |
| Macro | 23.6 | 15% |
| Liquidity | 65.0 | 5% |
Trade Setup
| Entry | 670.71 |
| Stop Loss | 619.75 (7.6%) |
| Target 1 (1:1) | 721.67 (+7.6%) |
| Target 2 (2:1) | 772.63 (+15.2%) |
| ATR(14) | 25.48 (3.8%) |
| Risk per Share | 50.96 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 5.3 | -1.79 | |
| Momentum | 88.2 | +1.53 | |
| Quality | 63.4 | +0.54 | |
| Composite | 52.3 | ||
Quality Scores
Piotroski F-Score
6
/9 —
Average
✓
✓
✗
✗
✓
✗
✓
✓
✓
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
Insufficient Data
Valuation vs Peers Overvalued
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | 45.2 | 22.0 | +105% above |
| P/B Ratio | 28.3 | 4.0 | Above |
| Dividend Yield | 0.0% | 1.5% | Below avg |
Comparing against Healthcare median multiples.
Trading at a premium to sector peers — verify growth justifies premium.
Intrinsic Value (DCF) Significantly Overvalued
Intrinsic Value
255.92
vs
Market Price
670.71
Upside
-61.8%
| Margin of Safety | -162.1% |
| Stage 1 PV (5yr FCF) | 4,793,882,322 |
| Terminal Value PV | 15,368,833,195 |
| Total Enterprise Value | 20,162,715,517 |
Assumptions
| Base FCF | 935,350,571 |
| Growth Rate (5yr) | 9.9% |
| Terminal Growth | 2.5% |
| Discount Rate (WACC) | 9.0% |
2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.
Position Sizing — Kelly Criterion
4.6%
Recommended Size
41.65%
Full Kelly
20.82%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 63/100. Estimated win rate 59%, avg win 8.8%, avg loss 3.7%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
RECOVERY
Regime: RECOVERY (40% confidence) — position size reduced 8%
Signal Summary BUY
3
Bullish Signals
2
Bearish Signals
70.28
RSI(14)
34.7054
MACD
Relative Strength (RS) IMPROVING
62
/ 99
RS Rating
O'Neil filter: <80
| RS vs SPY | ↑ RISING (+19.3% vs SPY 3M) |
| RS vs Sector | INLINE (Healthcare) |
| RS New High | ✓ RS at 3-month high Institutional accumulation signal |
| Sector Outperformance | +1.4% (3M) |
RS Line — stock / SPY (90 bars)
← older
newer →
RS vs SPY
50-day SMA of RS
IMPROVING:
Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 70.28 | OVERBOUGHT |
| Macd | 34.7054 | BULLISH |
| Ma Cross | 544.13 / 572.14 | DEATH CROSS |
| Trend Short | ABOVE SMA50 | |
| Trend Long | ABOVE SMA200 | |
| Bollinger | MIDDLE | |
| Volume | 1.23x | NORMAL |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 769.98 |
| Bollinger Upper | 686.33 |
| SMA(200) | 572.14 |
| SMA(50) | 544.13 |
| SMA(20) | 576.38 |
| Current Price | 670.71 |
| Bollinger Lower | 466.43 |
| 52-Week Low | 500.61 |
| ATR(14) | 25.48 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
MARKUP
Confidence
64%
Buying Climax
Sign of Strength
Acc: 0.0 |
Dist: 2.0 |
Markup: 3.5 |
Markdown: 0.0
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-10-30 | Normal | 1.66x | Normal bar — no special VSA pattern |
| 2026-11-02 | Normal | 2.79x | Normal bar — no special VSA pattern |
| 2026-11-03 | Normal | 1.68x | Normal bar — no special VSA pattern |
| 2026-11-04 | Normal | 1.97x | Normal bar — no special VSA pattern |
| 2026-11-05 | Normal | 1.23x | Normal bar — no special VSA pattern |
Ichimoku Cloud BULLISH
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 627.17 | Above Kijun |
| Kijun-sen (26) | 607.46 | Base line |
| Senkou A | 617.32 | Leading span A |
| Senkou B | 607.17 | Leading span B |
| Cloud | 607.17 – 617.32 | Bullish (Green) |
| Price vs Cloud | 670.71 | Above Cloud |
| Chikou Span | 517.75 | Bullish |
| Alignment Score | 4/4 | BULLISH |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE OFF
No squeeze
Momentum:
BULLISH FADING
BB: 466.43 – 686.33 | KC: 541.4 – 611.37
Divergences (last 60 bars)
No significant divergences detected in the last 60 bars.
Anchored VWAP
VWAP: 563.44
Anchor: 2026-09-11 (52w Low)
ABOVE AVWAP
+19.0%
Heikin-Ashi Trend
BULLISH
Full data via /api/advanced/IDXX
Valuation
| Metric | Value |
|---|---|
| Market Cap | 52.84B |
| P/E (TTM) | 45.20 |
| Forward P/E | N/A |
| P/B | 28.27 |
| EPS | 14.84 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | 9.9% |
| Profit Margin | 25.4% |
| ROE | 68.9% |
| Debt/Equity | 52.05 |
| Current Ratio | 1.19 |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Beta | 1.54 |
Trading Data
670.71
Open
670.71
Day High
670.71
Day Low
868.4K
Volume (1.5x avg)
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)